Kronox Lab Sciences IPO
KRONOX Lab Sciences Ltd., a prominent bulk manufacturer of high-purity fine chemicals, is set to launch its Initial Public Offering (IPO) from June 3 to June 5, 2024. The company has established itself as a reliable supplier in various industries, including pharmaceuticals, nutraceuticals, veterinary, food, chemical analysis, and other speciality markets. This blog provides an in-depth look at KRONOX Lab Sciences Ltd., its product portfolio, export reach, manufacturing facilities, financial performance, and the key details of its upcoming IPO. Company Overview KRONOX Lab Sciences Ltd. specializes in producing high-purity fine chemicals in compliance with Reagent, Pharmacopoeia, and various Food Grade standards. The company's advanced manufacturing capabilities, modern quality control standards, and robust research and development department enable it to cater to a broad spectrum of customer needs. The manufacturing facilities are located in Padra, Baroda, Gujarat, India. Product Portfolio
The company boasts an extensive array of over 185 products, catering to diverse industries and applications. Key product categories include Phosphate, Sulphate, Acetate, Chloride, Citrate, Nitrates, Nitrites, Carbonate etc. This comprehensive selection highlights the company's versatility and commitment to meeting a broad spectrum of customer needs. Global Export Reach
KRONOX Lab Sciences Ltd. exports its products to more than 20 countries worldwide, including:
United States
Australia
Egypt
Spain
United Kingdom
United Arab Emirates
China
This global presence underscores the company's reputation for quality and reliability in the international market. Manufacturing Facilities
The company's manufacturing facilities are strategically located in Vadodara, Gujarat, close to major seaports such as Mundra, Kandla, Hazira, and Nhava Sheva. Covering an area of 17,454 sq. m., these facilities have an installed capacity of 7,242 TPA as of December 31, 2023. Key certifications for Unit I/II include FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.
Financial Performance
KRONOX Lab Sciences Ltd. has demonstrated robust financial growth over recent years. Key financial metrics include:
Particulars | Dec-23 | Mar-23 | Mar-22 | Mar-21 |
Revenue from operations (₹ Cr) | 67.69 | 95.58 | 82.25 | 62.46 |
Net Worth (₹ Cr) | 60.28 | 44.68 | 40.35 | 26.81 |
Net Profit (₹ Cr) | 15.47 | 16.62 | 13.63 | 9.73 |
The company has consistently increased its net worth and net profit, reflecting its strong operational performance and growth trajectory. KRONOX Lab Sciences IPO: Key Details
IPO Dates: 3 to 5 June 2024
Price Band: ₹129 to ₹136 per share
Lot Size: 110 shares
Total Issue Size: ₹130.15 crores
Retail Quota: 35%
GMP: 30% (For informational purposes only)
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matters published here are purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. Any reader making decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in the stock market is subject to unpredictable market-related risks. The author has no plans to invest in this offer and also the author does not recommend investing in any offer published on this website.